Report overview
Oral Cancer Diagnostic is a doctor who discovers or diagnoses cancer through a series of tests on the mouth.
This report contains market size and forecasts of Oral Cancer Diagnostic in Global, including the following market information:
Global Oral Cancer Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Oral Cancer Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Computed Tomography (CT) Scan Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oral Cancer Diagnostic include GE Healthcare, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Siemens Healthineers, Hitachi Ltd, PeriRx, LLC, Canon Medical Systems Corporation?, Vigilant Biosciences, Inc. and QIAGEN and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oral Cancer Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Cancer Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oral Cancer Diagnostic Market Segment Percentages, by Type, 2021 (%)
Computed Tomography (CT) Scan
Magnetic Resonance Imaging (MRI)
Positron Emission Tomography (PET)
Ultrasonography
Biopsy
X-Ray
Endoscopy
Fluorescence Imaging
Others
Global Oral Cancer Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oral Cancer Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals and Clinics
Research and Academic Institutes
Others
Global Oral Cancer Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oral Cancer Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Cancer Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Oral Cancer Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Siemens Healthineers
Hitachi Ltd
PeriRx, LLC
Canon Medical Systems Corporation?
Vigilant Biosciences, Inc.
QIAGEN
Koninklijke Philips NV
